| Name | Title | Contact Details |
|---|
Established in 1995 by Jon Bauer, Janice Stanton and Gil Tenzer, Contrarian is a distressed investing specialist with one of the most stable portfolio management teams in the industry. Jon and Janice have been managing portfolios of distressed securities together since 1986 (joined by Gil in 1993) when they ran the Distressed Debt and Trade Claims businesses for Oppenheimer and Co. (“OPCO”). The continuity of senior management provides Contrarian with a significant competitive edge in sourcing and analyzing investment opportunities, as well as navigating the portfolio through multiple business cycles. Contrarian has a team of 53 highly experienced professionals, 29 of whom are involved with the portfolio management, research, sourcing and trading of our investments. Our global headquarters is in Greenwich (CT), with regional investment research offices in Paris (France), São Paulo (Brazil), and Hong Kong (China SAR). Contrarian is a 100% partner and employee owned, SEC registered investment adviser and Qualified Professional Asset Manager (“QPAM”).
Chicago Fundamental Investment Partners ("CFIP") is a credit focused investment management firm founded in 2005.
Reliant Equity Investors is a Chicago, IL-based company in the Financial Services sector.
Harris and Harris Group, Inc. builds transformative companies from disruptive science. We leverage our core scientific expertise to be FIRST in identifying new technology trends, in accessing high quality science and intellectual property, in building management teams and in executing on early-stage business growth. Our PROVEN team has the unique ability to identify and diligence the network of discoveries that come from understanding science at the intersection of different scientific disciplines, with biology as a focus. This places us at the center of the discoveries impacting some of the most important growth sectors of the economy, permitting us to build TRANSFORMATIVE companies. BIOLOGY+ is our distinctive approach. We define BIOLOGY+ as investments in interdisciplinary life science companies where biology innovation is intersecting with innovations in areas such as electronics, physics, materials science, chemistry, information technology, engineering and mathematics. We focus on this intersection because we believe interdisciplinary innovation will be required in order to address many of the life science challenges of the future.
Brevet Capital is a New York, NY-based company in the Financial Services sector.